Related Experiment Videos

Macro creatine kinase types 1 and 2: clinical significance in neonates and children as compared with adults

Clinical Chemistry
|January 1, 1983
PubMed

Insights

This study reports on macro creatine kinase (CK) in pediatric patients, identifying macro CK type 1 in children for the first time and linking macro CK type 2 to myocardial damage in children and malignancies in adults.

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Pediatrics

Background:

  • Creatine kinase (CK) is a crucial enzyme in cellular energy metabolism.
  • Macro creatine kinase (macro CK) is an uncommon form of CK, typically observed in adults.
  • Understanding macro CK prevalence and associations in pediatric populations is limited.

Observation:

  • Seven pediatric patients (4 days to 12 years) presented with significant macro CK activity.
  • Two pediatric cases of macro CK type 1 (CK-BB isoenzyme bound to IgG) were identified.
  • Five pediatric cases of macro CK type 2 (polymeric mitochondrial CK) were observed.

Findings:

  • Macro CK type 1, previously seen mainly in older women, is reported in children for the first time.
  • Four of five pediatric macro CK type 2 cases showed evident myocardial muscle damage.
  • Adult macro CK type 2 cases were predominantly associated with neoplasms, often with liver metastases.

Implications:

  • Macro CK type 1 occurrence in children broadens its known demographic profile.
  • Macro CK type 2 in pediatric patients may indicate myocardial damage, potentially reversible.
  • Macro CK type 2 in adults is a marker for poor prognosis in malignancies.

Related Concept Videos